OrigynMED raises Series B+ round
The multi-hundred millions yuan round was led by LAV, with participation from existing investors Eight Roads and Sequoia Capital China, etc.

As founding investor of OrigynMED, Eight Roads has focused on the women’s health area since 2008 and shares OrigynMED's vision of building a world-leading med tech platform company driven by indigenous innovation and cutting-edge technology.  

Founded in 2015, OriGynMED provides overall solutions and cost-effective innovative products for healthcare niches. The company plans to launch a first gynecology innovative medical device product portfolio in 2021, and initiate a national clinical medical education and training program centered on minimally invasive gynecological surgery.